Finoriq research workspace
Arbutus Biopharma Corp (ABUS) Historical Metrics
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel. Review ABUS fundamentals, ratios, and historical filing metrics on Finoriq.
Company Snapshot
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
- Company
- Arbutus Biopharma Corp (ABUS)
- Ticker
- ABUS
- Market Cap
- $878.1M
- Latest Price
- $4.445
- Industry
- Biotech & Pharma
Arbutus Biopharma Corp (ABUS) Current Valuation Metrics
Static valuation preview for Arbutus Biopharma Corp (ABUS). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/EMarket cap divided by latest TTM net income. | 6.34x | Net Income | TTM Q1 2026 |
| P/SMarket cap divided by latest TTM revenue. | 5.32x | Revenue | TTM Q1 2026 |
| Earnings YieldLatest TTM net income divided by market cap. | 15.8% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -3.4% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 3.92x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.